Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] iron-sulfur proteins comprise a series of essential subunits within mitochondrial Complex I, the first enzyme complex of the electron transport chain. These proteins catalyze electron transfer from NADH to ubiquinone via iron-sulfur clusters embedded in the protein subunits, contributing to the generation of the proton gradient used for ATP synthesis. Several specific subunits exist (e.g., NDUFS1, NDUFS4, NDUFS6, NDUFS8), each encoded by different nuclear genes and responsible for electron transfer or Complex I assembly. Mutations in these subunits are associated with mitochondrial diseases like Leigh syndrome and other dysfunctions involving oxidative phosphorylation. Complex I is a crucial metabolic enzyme and a validated drug target in contexts like neurodegeneration and metabolic diseases.
Inhibition of Complex I (blocks electron transfer, reduces ATP generation, can trigger cell death); Modulation of redox/ROS balance (by altering electron flow)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein chain (NDUFS (generic), or NDUFS1, NDUFS4, NDUFS6, NDUFS8, etc. for specific subunits).